Evidence map›Paper›PMID 36547452›Full record

ReviewJournal of cardiovascular development and disease2022

A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure.

Chun Shing Kwok, Duwarakan Satchithananda, Fozia Z Ahmed, Colin D Chue, Diane Barker, Ashish Patwala, Simon Duckett, Christian D Mallen

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. A Qualitative Study of the Limits and Possibilities of Integrating Palliative Care in Heart Failure.Inquiry : a journal of medical care organization, provision and financing
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Chun Shing KwokDepartment of Post-Qualifying Healthcare Practice, Birmingham City University, City South Campus, Birmingham B15 3TN, UK.ORCID 0000-0001-7047-1586
Duwarakan SatchithanandaDepartment of Cardiology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
Fozia Z AhmedDepartment of Cardiology, Manchester University NHS Foundation Trust, Manchester M13 9PL, UK.
Colin D ChueDepartment of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2WB, UK.
Diane BarkerDepartment of Cardiology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
Ashish PatwalaDepartment of Cardiology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
Simon DuckettDepartment of Cardiology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
Christian D MallenSchool of Medicine, Keele University, Keele ST5 5BG, UK.
University Hospitals of North Midlands NHS Trust · GBBirmingham City University · GBKeele University · GBManchester University NHS Foundation Trust · GBUniversity Hospitals Birmingham NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure (HF) is a global problem responsible for significant morbidity and mortality.

methodsThis review describes the patient pathways and missed opportunities related to treatment for patients with HF.

resultsThe contemporary management strategies in HF, including medical therapies, device therapy, transplant, and palliative care. Despite the strong evidence base for therapies that improve prognosis and symptoms, there remains a large number of patients that are not optimally managed. The treatment of patients with HF is highly influenced by those who are caring for them and varies widely across geographical regions. HF patients can be broadly classified into two key groups: those who have known HF, and those who are incidentally found to have reduced left ventricular systolic dysfunction or other cardiac abnormality when an echocardiogram is performed. While all patients are under the care of a general practitioner or family doctor, in other instances, non-cardiologist physicians, cardiologists, and specialist HF nurses-each will have varying levels of expertise in managing HF-are part of the broader team involved in the specialist management of patients with HF.

conclusionsThere are many potential missed opportunities in HF treatment, which include general opportunities, medications, etiology-specific therapy, device therapy, therapies when initial treatments fail, and palliative care.

Indexed as

heart failureopportunitiestherapytreatments

Identifiers

PMID36547452
PMCPMC9784521
OpenAlexW4312141343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.